Dissecting the role of extra centrosomes-induced exosome secretion in PDAC microenvironment

剖析额外中心体诱导的外泌体分泌在 PDAC 微环境中的作用

基本信息

  • 批准号:
    MR/T000538/1
  • 负责人:
  • 金额:
    $ 60.8万
  • 依托单位:
  • 依托单位国家:
    英国
  • 项目类别:
    Research Grant
  • 财政年份:
    2019
  • 资助国家:
    英国
  • 起止时间:
    2019 至 无数据
  • 项目状态:
    已结题

项目摘要

Despite progress, cancer is still a serious challenge in medicine. This is particularly true for pancreatic cancer, which has a dismal 5-year survival rate of <5%. This highly aggressive behaviour is cause in part caused by fibrosis, which forms a barrier around the tumour that hinders drug delivery and efficacy. This barrier is cause by changes in a cell population, named stellate cells, induced by the tumour. Combating fibrosis in pancreatic cancer is thus considered to be an important area for therapeutic intervention. We recently found that a population of cancer cells that carries amplification of a cellular organelle called centrosome is able to activate stellate cells. Centrosome amplification, an aberration that exists in cancer cells, was described in later 1800s as a possible cause of tumourigenesis. We now know that these abnormalities are a common feature of human tumours and can actively contribute to tumour formation. Published work from our lab was the first to identify a novel function of these abnormalities in influencing the surrounding cells (Arnandis et al., 2018). This work demonstrates that cancer cells with amplified centrosomes have a broader role in tumourigenesis than previously anticipated by communicating and changing other cells within tumours. In particular our new unpublished data shows that this communication between cancer cells with extra centrosomes and pancreatic stellate cells leads to their activation, which could contribute to fibrosis in PDAC. This is mediated via the release of small vesicles from cells with extra centrosomes, exosomes, that are packed with factors that will instruct stellate cells to become activated. Thus, understanding how cells with extra centrosomes activate stellate cells could help understanding fibrosis and lead to therapeutic strategies to treat pancreatic cancer patients.In this research proposal we aim to determine how centrosome amplification induces the release of exosomes and in turn how these vesicles activate stellate cells. We will use a combination of approaches, including live cell imaging, to identify the mechanisms responsible for exosome release. Furthermore, using well-established methods to identify the factors contained in these exosomes, we propose to uncover the molecules responsible for stellate cell activation. We will test if blocking the identified factors prevents stellate activation and fibrosis using 3-D culture models that mimic the interaction between cancer and stellate cells in tumours. Changes in signalling induced by exosomes in stellate cells will also be studied to understand the mechanisms of activate. This could be important to identify signatures of stellate cell activation and fibrosis in pancreatic tumours and will provide another opportunity to identify potential therapeutic targets to block fibrosis. Finally, we will use mouse models to test our findings in vivo. This will provide relevant pre-clinical models to assess the importance of our findings and test response to therapy. Thus, our work will not only contribute to understand for the first time the role of centrosomes amplification in tumour microenvironment but could also have a major impact in developing therapeutic strategies that target fibrosis to treat patients that suffer from pancreatic cancer.
尽管取得了进展,但癌症仍然是医学上的一个严重挑战。胰腺癌尤其如此,其5年生存率<5%。这种高度侵袭性的行为部分是由纤维化引起的,纤维化在肿瘤周围形成屏障,阻碍了药物的输送和疗效。这种屏障是由肿瘤引起的称为星状细胞的细胞群的变化引起的。因此,抗击胰腺癌纤维化被认为是治疗干预的一个重要领域。我们最近发现,一群癌细胞携带着一种叫做中心体的细胞器的扩增物,能够激活星状细胞。中心体扩增是存在于癌细胞中的一种畸变,在19世纪后期被描述为肿瘤发生的可能原因。我们现在知道,这些异常是人类肿瘤的共同特征,可以积极地促进肿瘤的形成。我们实验室发表的论文首次确定了这些异常在影响周围细胞方面的新功能(Arnandis et al., 2018)。这项工作表明,具有扩增中心体的癌细胞在肿瘤发生中具有比先前预期的更广泛的作用,通过交流和改变肿瘤内的其他细胞。特别是我们新的未发表的数据表明,具有额外中心体的癌细胞和胰腺星状细胞之间的这种通信导致它们的激活,这可能有助于PDAC的纤维化。这是通过带有额外中心体(外泌体)的细胞释放小囊泡介导的,这些外泌体充满了指示星状细胞被激活的因子。因此,了解具有额外中心体的细胞如何激活星状细胞可能有助于了解纤维化并制定治疗胰腺癌患者的治疗策略。在这项研究计划中,我们的目标是确定中心体扩增如何诱导外泌体的释放,以及这些囊泡如何激活星状细胞。我们将使用包括活细胞成像在内的多种方法来确定外泌体释放的机制。此外,使用成熟的方法来识别这些外泌体中包含的因子,我们建议揭示负责星状细胞激活的分子。我们将使用3d培养模型来模拟肿瘤中癌症和星状细胞之间的相互作用,测试阻断已确定的因素是否会阻止星状细胞激活和纤维化。星状细胞外泌体诱导的信号变化也将被研究,以了解激活的机制。这对于识别胰腺肿瘤中星状细胞活化和纤维化的特征可能是重要的,并将提供另一个机会来识别阻止纤维化的潜在治疗靶点。最后,我们将使用小鼠模型在体内测试我们的发现。这将提供相关的临床前模型来评估我们的发现的重要性和测试对治疗的反应。因此,我们的工作不仅有助于首次了解中心体扩增在肿瘤微环境中的作用,而且还可能对开发靶向纤维化治疗胰腺癌患者的治疗策略产生重大影响。

项目成果

期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
The principles of spindle bipolarity
主轴双极原理
Centrosome amplification fine-tunes tubulin acetylation to differentially control intracellular organization
中心体扩增微调微管蛋白乙酰化以差异控制细胞内组织
  • DOI:
    10.1101/2022.10.17.512471
  • 发表时间:
    2022
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Monteiro P
  • 通讯作者:
    Monteiro P
Centrosome amplification mediates small extracellular vesicle secretion via lysosome disruption.
  • DOI:
    10.1016/j.cub.2021.01.028
  • 发表时间:
    2021-04-12
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Adams SD;Csere J;D'angelo G;Carter EP;Romao M;Arnandis T;Dodel M;Kocher HM;Grose R;Raposo G;Mardakheh F;Godinho SA
  • 通讯作者:
    Godinho SA
Too close for comfort? Endomembranes promote missegregation by enclosing lost chromosomes.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Susana Godinho其他文献

Susana Godinho的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Susana Godinho', 18)}}的其他基金

Characterisation of the signalling pathways involved in cell invasion downstream of extra centrosomes
中心体外细胞侵袭下游信号通路的表征
  • 批准号:
    MR/M010414/1
  • 财政年份:
    2015
  • 资助金额:
    $ 60.8万
  • 项目类别:
    Research Grant

相似国自然基金

PfAP2-R介导的PfCRT转录调控在恶性疟原虫对喹啉类药物抗性中的作用及机制研究
  • 批准号:
    82372275
  • 批准年份:
    2023
  • 资助金额:
    49.00 万元
  • 项目类别:
    面上项目
Sestrin2抑制内质网应激对早产儿视网膜病变的调控作用及其机制研究
  • 批准号:
    82371070
  • 批准年份:
    2023
  • 资助金额:
    49.00 万元
  • 项目类别:
    面上项目

相似海外基金

Enhancer RNAs Boost MYC-Chromatin Interaction to Regulate Gene Expression and Tumorigenesis
增强子 RNA 促进 MYC-染色质相互作用以调节基因表达和肿瘤发生
  • 批准号:
    10716358
  • 财政年份:
    2023
  • 资助金额:
    $ 60.8万
  • 项目类别:
Combined bromodomain and CDK4/6 inhibition in NUT Carcinoma and other solid tumors
溴结构域和 CDK4/6 联合抑制 NUT 癌和其他实体瘤
  • 批准号:
    10577265
  • 财政年份:
    2023
  • 资助金额:
    $ 60.8万
  • 项目类别:
Project 2: Combination PARPi-BETi to Overcome PARPi Resistance
项目 2: PARPi-BETi 组合克服 PARPi 耐药性
  • 批准号:
    10713053
  • 财政年份:
    2023
  • 资助金额:
    $ 60.8万
  • 项目类别:
Working with rather than for partner organisations: re-defining the role of youth work in safeguarding young people from extra-familial harm.
与伙伴组织合作而不是为伙伴组织工作:重新定义青年工作在保护年轻人免受家庭外伤害方面的作用。
  • 批准号:
    2894580
  • 财政年份:
    2023
  • 资助金额:
    $ 60.8万
  • 项目类别:
    Studentship
Elucidating the effects of extra chromosome elimination in mosaic aneuploidy syndromes: Pallister-Killian syndrome as a model
阐明额外染色体消除对嵌合非整倍体综合征的影响:以 Pallister-Killian 综合征为模型
  • 批准号:
    10887038
  • 财政年份:
    2023
  • 资助金额:
    $ 60.8万
  • 项目类别:
Potentials of Epigenetic Molecules in Attenuating the Phenotypes of Periodontitis
表观遗传分子减轻牙周炎表型的潜力
  • 批准号:
    10736171
  • 财政年份:
    2023
  • 资助金额:
    $ 60.8万
  • 项目类别:
Exploring Small Molecule Inhibitors of PAF1C as Novel HIV Latency Reversal Agents
探索 PAF1C 小分子抑制剂作为新型 HIV 潜伏期逆转剂
  • 批准号:
    10762258
  • 财政年份:
    2023
  • 资助金额:
    $ 60.8万
  • 项目类别:
Targeting HNF1A-mediated therapeutic resistance in pancreatic ductal adenocarcinoma
靶向 HNF1A 介导的胰腺导管腺癌治疗耐药
  • 批准号:
    10561370
  • 财政年份:
    2023
  • 资助金额:
    $ 60.8万
  • 项目类别:
Does prenatal immune challenge result in increased extra-axial CSF volume?
产前免疫挑战是否会导致轴外脑脊液体积增加?
  • 批准号:
    10647969
  • 财政年份:
    2023
  • 资助金额:
    $ 60.8万
  • 项目类别:
Deciphering epigenetically-regulated pathways to improve targeted therapy for invasion and metastasis in head and neck cancer
破译表观遗传调控途径以改善头颈癌侵袭和转移的靶向治疗
  • 批准号:
    10650527
  • 财政年份:
    2023
  • 资助金额:
    $ 60.8万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了